Novo Nordisk (NVON) Q4 2022 Earnings Report
1 Followers
MX:NVON Q4 2022 EPS Results
- Actual EPS
- MXN 8.09
- Consensus EPS
- MXN 7.88
- Beat/Miss
- Beat by +MXN 0.21
- One Year Ago EPS
- MXN 6.76
MX:NVON Q4 2022 Revenue Results
- Actual Revenue
- MXN 123.42B
- Expected Revenue
- MXN 128.06B
- Beat/Miss
- Missed by -MXN 4.64B
- YoY Revenue Growth
- +11.88%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/01/2023
- Time
- Before Open
- Conference Call
- Wednesday, February 1, 2023
MX:NVON Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
MX:NVON Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVON Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.51- | 17.87 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.6916.29 | 12.96 | 25.72% (+3.33) | |
| Aug 04, 2026 | 2026 (Q2) | 14.4217.88 | 17.4 | 2.80% (+0.49) | |
| May 06, 2026 | 2026 (Q1) | 16.5519.53 | 18.63 | 4.82% (+0.90) | |
| Feb 04, 2026 | 2025 (Q4) | 17.2817.87 | 16.59 | 7.67% (+1.27) | |
| Nov 05, 2025 | 2025 (Q3) | 14.3112.96 | 16.5 | -21.45% (-3.54) | |
| Aug 06, 2025 | 2025 (Q2) | 17.2117.40 | 12.32 | 41.19% (+5.07) | |
| May 07, 2025 | 2025 (Q1) | 17.1318.63 | 15.24 | 22.24% (+3.39) | |
| Feb 05, 2025 | 2024 (Q4) | 15.5616.59 | 13.41 | 23.74% (+3.18) | |
| Nov 06, 2024 | 2024 (Q3) | 16.4816.50 | 13.31 | 23.91% (+3.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
